Vera Therapeutics VERA Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vera Therapeutics's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vera Therapeutics's net change in cash?
- Vera Therapeutics (VERA) reported net change in cash of -$240.37M in Q1 2026.
- How has Vera Therapeutics's net change in cash changed year-over-year?
- Vera Therapeutics's net change in cash decreased by 540.0% year-over-year, from -$37.56M to -$240.37M.
- What is the long-term trend for Vera Therapeutics's net change in cash?
- Over 2 years (2023 to 2025), Vera Therapeutics's net change in cash has grown at a 1065.6% compound annual growth rate (CAGR), from $1.93M to $262.08M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.